Michael A. Metzger - 09 Mar 2022 Form 4 Insider Report for CTI BIOPHARMA CORP

Role
Director
Signature
/s/ Bruce Seeley, attorney-in-fact for Michael A. Metzger
Issuer symbol
N/A
Transactions as of
09 Mar 2022
Net transactions value
$0
Form type
4
Filing time
11 Mar 2022, 18:43:57 UTC
Previous filing
03 Feb 2022
Next filing
07 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTIC Stock Option (right to buy) Award $0 +80,000 $0.000000 80,000 09 Mar 2022 Common Stock 80,000 $4.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2023 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event.